Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplastic Cells, Circulating × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 336 Polycystic Ovary Syndrome 37 Neoplasm Metastasis 21 Endometrial Neoplasms 21 Ovarian Neoplasms 16 Neoplasms 13 Infertility 9 Advanced Breast Cancer 9 Fallopian Tube Neoplasms 8 Recurrence 7 Carcinoma, Intraductal, Noninfiltrating 7 Carcinoma, Ductal, Breast 7 Osteoporosis 6 Carcinoma, Lobular 6 Breast Neoplasms, Male 6 Breast Diseases 6 Triple Negative Breast Neoplasms 5 Breast Carcinoma In Situ 5 Prostatic Neoplasms 4 Leiomyoma 4 Infertility, Female 4 Hereditary Sensory and Autonomic Neuropathies 4 Breast Cancer Metastatic 4 Arthralgia 4 Obesity 3 Neoplasms, Hormone-Dependent 3 Carcinoma, Ovarian Epithelial 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2

Interventions

Blood Specimen Collection 25 Surgical Procedures, Operative 4 Liquid Biopsy 4 cabazitaxel 3 Trastuzumab 3 Reverse Transcriptase Polymerase Chain Reaction 3 Propofol 3 Flow Cytometry 3 Bevacizumab 3 Spinal Puncture 2 Sevoflurane 2 Positron Emission Tomography Computed Tomography 2 Pirinitramide 2 Neoadjuvant Therapy 2 Morphine 2 Laparoscopy 2 Gemcitabine 2 Folfox protocol 2 Docetaxel 2 Cisplatin 2 Carboplatin 2 Capecitabine 2 Aspirin 2 Anesthesia, General 2 ribociclib 1 pertuzumab 1 osimertinib 1 lanreotide 1 jinfukang 1 eribulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02958852 2025-09-10

ABC-SE

Lund University Hospital

Phase 2 Completed

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡